Article
06 Sep 2023
Patenting Computer-implemented Inventions In Australia After Aristocrat
AUTHORS CONTENT
Article
22 Nov 2022
High Court Powers Down DABUS Patent Prospects In Australia
Article
09 Aug 2022
Clinical Trial Disclosures A Significant Risk To Patent Validity In Australia
Article
02 Aug 2022
The Fiction, Function And Formulation Of Swiss-style Claims In New Zealand
Article
23 Jun 2022
The Whole Story Of "Whole Of Contents" Novelty In Australia And New Zealand
Article
22 Apr 2022
Australian Appeal Court Denies AI Inventor Status
Article
20 Apr 2022
DABUS Update: Australian Appeal Court Denies AI Inventor Status
Article
07 Apr 2022
An Important Month For PTE In Australia: What Pharmaceutical Patentees Need To Know
Article
23 Mar 2022
IPONZ Draws Clear Line Between Patentable Subject Matter And Double Patenting
Article
02 Mar 2022
IPONZ Draws Clear Line Between Patent Subject Matter And Double Patenting
Article
23 Feb 2022
DABUS Update: New Zealand Patent Office Rejects AI Inventorship
Article
19 Aug 2021
Last Call For Innovation Patents In Australia
Article
19 Aug 2021
Double Victory Over Double Patenting In New Zealand
Article
05 Aug 2021
One Small Step For Man, One Giant Leap For AI: Australian Court Finds DABUS Can Be An Inventor
Article
19 Jul 2021
Patentability Of Biotech Inventions In Australia – Another Victory For Sequenom
Article
24 Jun 2021
Judicial Review Finds PTEs Based On Third Party Products To Be "manifestly Absurd"
Article
03 May 2021
Late Filing Of Patent Applications In Australia And New Zealand
Article
25 Nov 2020
Australian Patent Office Re-affirms PTE Independent Of Product Ownership
Article
17 Aug 2020
Act Now To Avoid IP Australia Fee Increases
Article
20 Jul 2020
Reading Between The Lines When Assessing Novelty Of Patent Claims